Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation

Morgan B Slater^{1

2}, Andrea Gruneir^{3

4

5

6}, Paula A Rochon^{4

5

6

7}, Andrew W Howard^{2

5

8

9}, Gideon Koren¹⁰, Christopher S Parshuram^{11

12

13

14

15}

Affiliations

¹ Department of Critical Care Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
² Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.
³ Department of Family Medicine, University of Alberta, Edmonton, AB, Canada.
⁴ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
⁵ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
⁶ Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
⁷ Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁸ Division of Orthopaedic Surgery, The Hospital for Sick Children, Toronto, ON, Canada.
⁹ Department of Surgery, University of Toronto, Toronto, ON, Canada.
¹⁰ Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
¹¹ Department of Critical Care Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. chris@sickkids.ca.
¹² Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada. chris@sickkids.ca.
¹³ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. chris@sickkids.ca.
¹⁴ Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON, Canada. chris@sickkids.ca.
¹⁵ Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada. chris@sickkids.ca.

PMID: 27943125
DOI: 10.1007/s40272-016-0205-1

Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation

Morgan B Slater et al. Paediatr Drugs. 2017 Feb.

. 2017 Feb;19(1):59-67.

doi: 10.1007/s40272-016-0205-1.

Authors

Morgan B Slater^{1

2}, Andrea Gruneir^{3

4

5

6}, Paula A Rochon^{4

5

6

7}, Andrew W Howard^{2

5

8

9}, Gideon Koren¹⁰, Christopher S Parshuram^{11

12

13

14

15}

Affiliations

¹ Department of Critical Care Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
² Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.
³ Department of Family Medicine, University of Alberta, Edmonton, AB, Canada.
⁴ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
⁵ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
⁶ Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
⁷ Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁸ Division of Orthopaedic Surgery, The Hospital for Sick Children, Toronto, ON, Canada.
⁹ Department of Surgery, University of Toronto, Toronto, ON, Canada.
¹⁰ Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
¹¹ Department of Critical Care Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. chris@sickkids.ca.
¹² Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada. chris@sickkids.ca.
¹³ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. chris@sickkids.ca.
¹⁴ Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON, Canada. chris@sickkids.ca.
¹⁵ Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada. chris@sickkids.ca.

PMID: 27943125
DOI: 10.1007/s40272-016-0205-1

Abstract

Background: Nephrotoxic medications are a common cause of acute kidney injury (AKI). Critically ill children receive more medication than other inpatients; however, the risk of nephrotoxic medication-induced AKI in these children is not well understood.

Objective: The aim of this study was to determine the association between exposure to nephrotoxic medications in the intensive care unit (ICU) and the development of AKI amongst critically ill children, adjusting for differences in underlying risk.

Methods: We conducted a nested case-control study among a cohort of patients admitted to a paediatric intensive care unit between January 2006 and June 2009. Cases were identified according to the RIFLE criteria. Using incidence density sampling, controls were matched 1:1 according to pre-ICU nephrotoxic drug exposure. Administration of nephrotoxic medications and other known risk factors of AKI were evaluated during the ICU stay prior to the diagnosis of AKI.

Results: A total of 914 patients in the cohort developed AKI and had an identifiable matched control. Eighty-seven percent of cases and 74% of controls were exposed to one or more nephrotoxic medications in the ICU during the study period. Furosemide (administered to 67.8% of patients), vancomycin (28.7%), and gentamicin (21.4%) were the most frequently administered nephrotoxic drugs. Patients who developed AKI were more likely to be exposed to at least one nephrotoxic medication and risk increased with increasing number of nephrotoxic medications. Ganciclovir (adjusted odds ratio [AOR] 4.7; 95% CI 1.7-13.0), furosemide (AOR 1.9; 95% CI 1.4-2.4), and gentamicin (AOR 1.8; 95% CI 1.4-2.4) significantly increased the odds of developing AKI after adjusting for underlying differences in risk factors of AKI.

Conclusion: This is the first study to assess the association between risk-adjusted nephrotoxic medication exposure and the development of AKI in critically ill children. Nephrotoxic medication exposure was common amongst children in the ICU and we found AKI was associated with the administration of specific drugs after adjustment for important risk factors.

PubMed Disclaimer

References

1. J Pediatr. 2015 Jun;166(6):1462-8.e1-4 - PubMed
1. Cardiorenal Med. 2013 Apr;3(1):26-37 - PubMed
1. Kidney Int. 2010 Mar;77(6):536-42 - PubMed
1. Am J Kidney Dis. 2005 Jan;45(1):96-101 - PubMed
1. J Matern Fetal Neonatal Med. 2014 Sep;27(14):1485-90 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation

Affiliations

Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation

Authors

Affiliations

Abstract

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical